Phase 1 Myopia Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control
Myopia
Ruihua Wei410 enrolled1 locationNCT06523504
Completed
Phase 1
Safety and tolerability trial of an eye drop treatment for short sightedness (myopia)
Myopia
University of Canberra30 enrolled1 locationACTRN12620001259932
Completed
Phase 1
Effect of atropine eye drops on thinning of the ocular choroid induced by retinal image defocus in adults with myopia (near-sightedness)
Myopia
The University of Auckland12 enrolled1 locationACTRN12617001519347